RP9P and colorectal carcinoma: The dual-luciferase reporter assay showed that the miR-133a-3p mimic remarkably decreased (Figure 4F) while the inhibitor increased (Figure 4G) the relative luciferase intensity of the reporter containing wild-type RP9P in CRC cells; however, no significant changes were found in the mutant group.